Basic Information
RNALocate ID: | RLID-D:11000185 |
RNA Symbol: | hsa-miR-199b-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-199b-3p |
RNA ID: | miRBase:MIMAT0004563 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
Tissue/Cell Line: | Mast cells |
Database: | EVmiRNA |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11003674 | Exosome | Plasma | 23663360 |
RLID:11003675 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
RLID:11003676 | Microvesicle | Plasma | 23077538 |
RLID-D:11000609 | Microvesicle | Breast cell line|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-199b-3p | Medulloblastoma | MNDR-E-MI-25012 |
MNDR | hsa-miR-199b-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-25013 |
MNDR | hsa-miR-199b-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-25014 |
MNDR | hsa-miR-199b-3p | Lymphoma | MNDR-E-MI-25015 |
MNDR | hsa-miR-199b-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-25016 |
MNDR | hsa-miR-199b-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-25017 |
MNDR | hsa-miR-199b-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-25018 |
MNDR | hsa-miR-199b-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-25019 |
MNDR | hsa-miR-199b-3p | Breast cancer luminal | MNDR-E-MI-25020 |
MNDR | hsa-miR-199b-3p | Prostate cancer | MNDR-E-MI-25021 |
MNDR | hsa-miR-199b-3p | Alzheimer disease | MNDR-E-MI-25022 |
MNDR | hsa-miR-199b-3p | Polycystic ovary syndrome | MNDR-E-MI-25023 |
MNDR | hsa-miR-199b-3p | Huntington disease | MNDR-E-MI-25024 |
MNDR | hsa-miR-199b-3p | Chorea | MNDR-E-MI-25025 |
MNDR | hsa-miR-199b-3p | Carotid stenosis | MNDR-E-MI-25026 |
MNDR | hsa-miR-199b-3p | Parkinson disease | MNDR-E-MI-25027 |
MNDR | hsa-miR-199b-3p | Basal-like breast cancer | MNDR-E-MI-25028 |
MNDR | hsa-miR-199b-3p | Pancreatic cancer | MNDR-E-MI-25029 |
MNDR | hsa-miR-199b-3p | Rectum adenocarcinoma | MNDR-E-MI-25030 |
MNDR | hsa-miR-199b-3p | Nephroblastoma | MNDR-E-MI-25031 |
MNDR | hsa-miR-199b-3p | Colon adenocarcinoma | MNDR-E-MI-25032 |
MNDR | hsa-miR-199b-3p | Prostate adenocarcinoma | MNDR-E-MI-25033 |
MNDR | hsa-miR-199b-3p | Glioblastoma | MNDR-E-MI-25034 |
MNDR | hsa-miR-199b-3p | Gastric adenocarcinoma | MNDR-E-MI-25035 |
MNDR | hsa-miR-199b-3p | Lung squamous cell carcinoma | MNDR-E-MI-25036 |
MNDR | hsa-miR-199b-3p | Lung adenocarcinoma | MNDR-E-MI-25037 |
MNDR | hsa-miR-199b-3p | Thyroid carcinoma | MNDR-E-MI-25038 |
MNDR | hsa-miR-199b-3p | Ovarian carcinoma | MNDR-E-MI-25039 |
MNDR | hsa-miR-199b-3p | Bladder urothelial carcinoma | MNDR-E-MI-25040 |
MNDR | hsa-miR-199b-3p | Pancreatic adenocarcinoma | MNDR-E-MI-25041 |
MNDR | hsa-miR-199b-3p | Carcinoma renal cell | MNDR-E-MI-25042 |
MNDR | hsa-miR-199b-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-25043 |
MNDR | hsa-miR-199b-3p | Renal clear cell carcinoma | MNDR-E-MI-25044 |
MNDR | hsa-miR-199b-3p | Adenocarcinoma of esophagus | MNDR-E-MI-25045 |
MNDR | hsa-miR-199b-3p | Lung small cell carcinoma | MNDR-E-MI-25046 |
MNDR | hsa-miR-199b-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-25047 |
MNDR | hsa-miR-199b-3p | Hepatocellular carcinoma | MNDR-E-MI-25048 |
MNDR | hsa-miR-199b-3p | Rheumatoid arthritis | MNDR-E-MI-25049 |
MNDR | hsa-miR-199b-3p | Multiple myeloma | MNDR-E-MI-25050 |
MNDR | hsa-miR-199b-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-25051 |
MNDR | hsa-miR-199b-3p | Venous thromboembolism | MNDR-E-MI-25052 |
MNDR | hsa-miR-199b-3p | Stroke lacunar | MNDR-E-MI-25053 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ITGA3 | Homo sapiens | RR00761894 |
TOP